名稱 | CCR4/Ga15/CHO |
型號(hào) | CBP71336 |
報(bào)價(jià) | |
特點(diǎn) | CCR4/Ga15/CHO 凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 【新品上線】多重病原菌質(zhì)控品
- 【盤點(diǎn)】癌癥免疫檢查點(diǎn)療法的現(xiàn)狀與展望
- 偏頭痛治療靶點(diǎn)——CGRP與藥篩細(xì)胞模型
- ATCC細(xì)胞如何培養(yǎng)?
- 細(xì)胞株定期維護(hù)與監(jiān)測(cè)要做好哪些?
- 【產(chǎn)品推介】VEGFR-2(KDR)小分子抑制劑細(xì)胞篩選模型
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71336CCR4/Ga15/CHO
- 詳細(xì)內(nèi)容
CBP71336 | |
I. Background | |
C-C chemokine receptor type 4 is a protein that in humans is encoded by the CCR4 gene.The protein encoded by this gene belongs to the G protein-coupled receptor family. It is a receptor for the following CC chemokines:CCL2 (MCP-1) CCL4 (MIP-1) CCL5 (RANTES) CCL17 (TARC) CCL22 (Macrophage-derived chemokine). Chemokines are a group of small structurally related proteins that regulate cell trafficking of various types of leukocytes. The chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. | |
II. Introduction | |
Host Cell: | CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+100μg/ml Hygromycin B+200μg/ml G418 |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for CCR4 receptor |
Transducer: | Gi |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data | |
Figure 1. Dose Response of Recombinant Human CCL22 in CCR4/Gα15 CHO cells(C11). |